Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CRS-3123 by Crestone for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
CRS-3123 is under clinical development by Crestone and currently in Phase II for Clostridioides difficile Infections (Clostridium difficile Associated Disease)....